A charity will pay $4 million to resolve claims that it acted as a conduit for companies including Biogen and Novartis to pay kickbacks to patients using their high-priced multiple sclerosis drugs
A top U.S. pharmacy benefit manager (PBM) owned by UnitedHealth Group Inc has included new migraine drugs from Amgen Inc and Eli Lilly and Co as preferred treatments on its lists of covered drugs, according to an OptumRx client note viewed by Reuters.